TEARS NATURALE FORTE 0.1 % — DIN 02246397
DEXTRAN 70 : 0.1 % GLYCERINE : 0.2 % HYPROMELLOSE : 0.3 % · ALCON CANADA INC · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is TEARS NATURALE FORTE?
TEARS NATURALE FORTE 0.1 % contains DEXTRAN 70 : 0.1 % GLYCERINE : 0.2 % HYPROMELLOSE : 0.3 %. It is listed in the Health Canada Drug Product Database under DIN 02246397, held by ALCON CANADA INC, supplied as SOLUTION for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 17-Oct-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Is there a generic Artificial Tears And Other Indifferent Preparations. in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
31 holders have a Canadian DIN containing Artificial Tears And Other Indifferent Preparations., across 94 DINs, of which 26 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ABBVIE CORPORATION | 12 | 9 | REFRESH, REFRESH CELLUVISC, REFRESH CONTACTS, REFRESH LACRI-LUBE, REFRESH LIQUIGEL, +7 more | Sourceable in Canada |
| ALCON CANADA INC | 21 | 5 | ALCON TEARS 0.5%, ALCON TEARS 1%, ARTIFICIAL TEARS, BION TEARS - LIQ OPH, COOL EYE DROPS, +16 more | Sourceable in Canada |
| BAUSCH & LOMB INC | 9 | 5 | ARTELAC LUBRICANT EYE DROPS, LACRISERT, LUBRICANT EYE DROPS, LUBRICANT EYE DROPS/ ARTIFICIAL TEARS, MIEBO, +4 more | Sourceable in Canada |
| JUNO OTC INC | 2 | 2 | ARTIFICIAL TEARS, DRY EYE TEARS | Sourceable in Canada |
| MEDTECH PRODUCTS INC | 2 | 2 | PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS, THERATEARS LUBRICANT EYE DROPS | Sourceable in Canada |
| JOHNSON & JOHNSON INC | 5 | 1 | VISINE CONTACT LENS, VISINE FOR DRY EYE ENVIRONMENTAL RELIEF, VISINE FOR DRY EYE EYE REVIVAL, VISINE FOR DRY EYE TIRED EYE RELIEF, VISINE FOR DRY EYE TRUE TEARS | Sourceable in Canada |
| AMO CANADA COMPANY | 2 | 1 | AMO ENDOSOL EXTRA, AMO ENDOSOL SOLUTION | Sourceable in Canada |
| PRESTIGE BRANDS INC | 2 | 1 | CLEAR EYES FOR DRY EYES, MURINE | Sourceable in Canada |
| ALLERGAN INC | 7 | 0 | CELLUFRESH LIQ 0.5%, LACRIL 0.5% DPS, LIQUIFILM FORTE 3%, LIQUIFILM TEARS, REFRESH OPTIVE, +2 more | No marketed DIN |
| PHARMASCIENCE INC | 3 | 0 | ARTIFICIAL TEARS EXTRA, PMS-ARTIFICIAL TEARS DPS 1.4%, PMS-ARTIFICIAL TEARS PLUS SOL | No marketed DIN |
| BAUSCH & LOMB CANADA INC. | 2 | 0 | MOISTURE DROPS, MUROCEL LIQ 1% | No marketed DIN |
| IVAX PHARMACEUTICALS INCORPORATED | 2 | 0 | ARTIFICIAL TEARS, ARTIFICIAL TEARS PLUS | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 0.1 % |
|---|---|
| Dosage form | SOLUTION |
| Route | OPHTHALMIC |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Artificial Tears And Other Indifferent Preparations. |
|---|---|
| ATC code | S01XA20 |
| AHFS class | 28:08.04.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02246397 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2246397 |
| Brand name | TEARS NATURALE FORTE |
| Generic / active ingredient | DEXTRAN 70 : 0.1 % GLYCERINE : 0.2 % HYPROMELLOSE : 0.3 % |
| Market authorization holder | ALCON CANADA INC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | S01XA20 |
| ATC anatomical main group | S — Sensory organs |
| ATC therapeutic subgroup | S01XA |
| Current status | MARKETED |
| Status date | 17-Oct-2019 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
26 of 94 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALCON TEARS 0.5% | 0.5 % | SOLUTION | ALCON CANADA INC | MARKETED | 00000809 |
| ALCON TEARS 1% | 1 % | SOLUTION | ALCON CANADA INC | MARKETED | 00000817 |
| AMO ENDOSOL SOLUTION | 0.17 % | SOLUTION | AMO CANADA COMPANY | MARKETED | 02007967 |
| ARTIFICIAL TEARS | 0.2 % | SOLUTION | JUNO OTC INC | MARKETED | 02354535 |
| DRY EYE TEARS | 0.2 % | SOLUTION | JUNO OTC INC | MARKETED | 02389886 |
| LUBRICANT EYE DROPS/ ARTIFICIAL TEARS | 0.3 % | DROPS | BAUSCH & LOMB INC | MARKETED | 02321696 |
| MIEBO | 100 % | SOLUTION | BAUSCH & LOMB INC | MARKETED | 02551403 |
| MURINE | 6 MG | SOLUTION | PRESTIGE BRANDS INC | MARKETED | 02247538 |
| PRESERVATIVE-FREE THERA TEARS LUBRICANT EYE DROPS | 0.25 % | DROPS | MEDTECH PRODUCTS INC | MARKETED | 02242082 |
| REFRESH | 1.4 % | DROPS | ABBVIE CORPORATION | MARKETED | 02138670 |
2 · Same class — other molecules in ATC S01XA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Artificial Tears And Other Indifferent Preparations. | ALCON TEARS 0.5% · ALCON TEARS 1% · AMO ENDOSOL EXTRA · AMO ENDOSOL SOLUTION · +84 more | 94 | 26 | Yes |
| Ciclosporin | CEQUA · RESTASIS · RESTASIS MULTIDOSE · TEVA-CYCLOSPORINE | 4 | 4 | Yes |
| Mercaptamine | CYSTADROPS | 1 | 1 | Yes |
| Voretigene Neparvovec | LUXTURNA | 1 | 1 | Yes |
| Ocriplasmin | JETREA | 2 | 0 | Not in Canada |
| Sodium Chloride, Hypertonic | EYESALINE EYEWASH · MURO 128 OPH SOLN 2% | 2 | 0 | Not in Canada |
| Cenegermin | OXERVATE | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.